A detailed history of Wetherby Asset Management Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Wetherby Asset Management Inc holds 77,070 shares of AZN stock, worth $4.98 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares
77,070
Previous 75,235 2.44%
Holding current value
$4.98 Million
Previous $5.87 Million 2.35%
% of portfolio
0.28%
Previous 0.28%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$76.67 - $87.62 $140,689 - $160,782
1,835 Added 2.44%
77,070 $6.01 Million
Q2 2024

Aug 14, 2024

BUY
$66.81 - $80.83 $150,856 - $182,514
2,258 Added 3.09%
75,235 $5.87 Million
Q1 2024

May 15, 2024

BUY
$61.03 - $69.57 $92,460 - $105,398
1,515 Added 2.12%
72,977 $4.94 Million
Q4 2023

Feb 14, 2024

BUY
$61.89 - $69.28 $2,228 - $2,494
36 Added 0.05%
71,462 $4.81 Million
Q3 2023

Nov 14, 2023

SELL
$64.85 - $71.7 $94,680 - $104,682
-1,460 Reduced 2.0%
71,426 $4.84 Million
Q2 2023

Aug 14, 2023

BUY
$69.91 - $75.81 $245,943 - $266,699
3,518 Added 5.07%
72,886 $5.22 Million
Q1 2023

May 12, 2023

BUY
$63.15 - $71.6 $50,267 - $56,993
796 Added 1.16%
69,368 $4.81 Million
Q4 2022

Feb 14, 2023

BUY
$54.21 - $70.44 $197,432 - $256,542
3,642 Added 5.61%
68,572 $4.65 Million
Q3 2022

Nov 14, 2022

SELL
$53.02 - $135.75 $24,283 - $62,173
-458 Reduced 0.7%
64,930 $3.56 Million
Q2 2022

Aug 15, 2022

BUY
$59.26 - $71.14 $352,122 - $422,713
5,942 Added 10.0%
65,388 $4.32 Million
Q1 2022

May 16, 2022

BUY
$55.72 - $67.12 $163,761 - $197,265
2,939 Added 5.2%
59,446 $3.94 Million
Q4 2021

Feb 14, 2022

SELL
$54.02 - $63.83 $6,590 - $7,787
-122 Reduced 0.22%
56,507 $3.29 Million
Q3 2021

Nov 15, 2021

BUY
$55.56 - $60.79 $154,234 - $168,753
2,776 Added 5.15%
56,629 $3.4 Million
Q2 2021

Aug 16, 2021

BUY
$48.42 - $60.18 $49,097 - $61,022
1,014 Added 1.92%
53,853 $3.23 Million
Q1 2021

May 14, 2021

SELL
$47.16 - $54.44 $77,483 - $89,444
-1,643 Reduced 3.02%
52,839 $2.63 Million
Q4 2020

Feb 11, 2021

BUY
$48.52 - $58.02 $2.48 Million - $2.97 Million
51,186 Added 1552.97%
54,482 $2.72 Million
Q3 2020

Dec 16, 2020

SELL
$53.07 - $61.1 $2.59 Million - $2.98 Million
-48,783 Reduced 93.67%
3,296 $181,000
Q3 2020

Dec 16, 2020

SELL
$53.07 - $61.1 $201,984 - $232,546
-3,806 Reduced 6.81%
52,079 $2.85 Million
Q3 2020

Nov 13, 2020

BUY
$53.07 - $61.1 $6,474 - $7,454
122 Added 0.22%
55,885 $3.06 Million
Q2 2020

Aug 14, 2020

BUY
$43.1 - $55.31 $72,580 - $93,142
1,684 Added 3.11%
55,763 $2.95 Million
Q1 2020

May 06, 2020

BUY
$37.79 - $51.33 $202,025 - $274,410
5,346 Added 10.97%
54,079 $2.42 Million
Q4 2019

Jan 28, 2020

SELL
$42.46 - $50.46 $33,118 - $39,358
-780 Reduced 1.58%
48,733 $2.43 Million
Q3 2019

Oct 31, 2019

BUY
$40.12 - $45.47 $123,449 - $139,911
3,077 Added 6.63%
49,513 $2.21 Million
Q2 2019

Jul 25, 2019

BUY
$37.28 - $41.68 $23,411 - $26,175
628 Added 1.37%
46,436 $1.92 Million
Q1 2019

May 09, 2019

BUY
$35.49 - $43.02 $45,001 - $54,549
1,268 Added 2.85%
45,808 $1.85 Million
Q4 2018

Jan 30, 2019

BUY
$36.86 - $41.49 $78,216 - $88,041
2,122 Added 5.0%
44,540 $1.69 Million
Q3 2018

Nov 07, 2018

BUY
$34.76 - $39.72 $278 - $317
8 Added 0.02%
42,418 $1.68 Million
Q2 2018

Jul 24, 2018

BUY
$34.55 - $37.05 $88,931 - $95,366
2,574 Added 6.46%
42,410 $1.49 Million
Q1 2018

May 04, 2018

BUY
$32.97 - $36.63 $66,830 - $74,249
2,027 Added 5.36%
39,836 $1.39 Million
Q4 2017

Feb 09, 2018

BUY
$32.09 - $34.78 $62,029 - $67,229
1,933 Added 5.39%
37,809 $1.31 Million
Q3 2017

Nov 13, 2017

BUY
$28.96 - $34.0 $1.04 Million - $1.22 Million
35,876
35,876 $1.22 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $200B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Wetherby Asset Management Inc Portfolio

Follow Wetherby Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wetherby Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wetherby Asset Management Inc with notifications on news.